Treatment of anaemia in cancer patients: implications for supportive care in the National Health Service Cancer Plan

References

• Bron D. Biological Basis of cancer related anaemia. In: Marty M, Pecorelli S. eds. European School of Oncology Scientific Updates. Fatigue and Cancer. Amsterdam: Elsevier, 2001
   Google Scholar
• Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver and oncologist perceptions of cancer-related fatigue. Semin Hematol 1997;34:4–12
   PubMed Web of Science ®Google Scholar
• Curt A, Breitbart W, Cella D, et al. Impact of cancer related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 2000;5:353–60
   PubMedGoogle Scholar
• Curt A. Fatigue in cancer. BMJ 2001;322:1560
   PubMedGoogle Scholar
• Stone P, Richardson A, Ream E, et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of multi-centre patients survey. Ann Oncol 2000;11:971–5
   PubMed Web of Science ®Google Scholar
• Cavill I. Reducing blood transfusion, BMJ 2002;325:656
   Google Scholar
• IMS Health. HPA hospital audit data. Sandwich: IMS, 2003
   Google Scholar
• Department of Health. Hospital Episodes Statistics England 2001–02. London: Department of Health 2002
   Google Scholar
• Marangolo M, Papiani G. Treating anaemia in cancer patients: improving their quality of life. Anaemia Cancer 2002;3(3):59–65
   Google Scholar
• Glaspy J, Bukowski R, Steinberg D, et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 1997;15:1218–34
   PubMed Web of Science ®Google Scholar
• Demetri GD, Kris M, Wade J, et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 1998;16:3412–25
   PubMed Web of Science ®Google Scholar
• Gabrilove JL, Cleeland CS, Livingston RB, et al. Clinical evaluation of once weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three times weekly dosing. J Clin Oncol 2001;19:2875–82
   PubMed Web of Science ®Google Scholar
• Dammacco F, Silverstris F, Castoldi GL, et al. The effectiveness and tolerability of epoetin alfa in patients with multiple myeloma. Br J Haematol 2001;113, 172–9
   PubMed Web of Science ®Google Scholar
• Crawford J, Cella D, Cleeland CS, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer 2002;95:888–95
   PubMed Web of Science ®Google Scholar
• Littlewood TJ, Bajetta E, Nortier JWR, et al. Effects of epoetin alfa on haematological parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomised, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865–74
   PubMed Web of Science ®Google Scholar
• Fallowfield L, Gagnon D, Zagari M, et al. Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br J Cancer 2002;87:1341–53
   PubMed Web of Science ®Google Scholar
• Cella D, Zagari M, Vandoros C, et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 2003;21:366–73
   PubMed Web of Science ®Google Scholar
• Osterborg A, Brandberg Y, Molostova V, et al. Randomised, double blind, placebo controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies. J Clin Oncol 2002;20:2486–94
   PubMed Web of Science ®Google Scholar
• Vansteenkiste J, Pirker R Masssuti B, et al. Double blind, placebo controlled, randomised phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy. J Natl Cancer Inst 2002;94:1211–20
   PubMed Web of Science ®Google Scholar
• Hedenus M, Adriansson M, San Miguel J, et al. Efficacy and safety of darbepoetin in anaemic patients with lymphoproliferative malignancies: a randomised, double blind, placebo controlled study. Br J Haematol 2003;122:394–403
   PubMed Web of Science ®Google Scholar
• Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528–36
   PubMed Web of Science ®Google Scholar
• Martin SC, Gagnon D, Zhang L, et al. Cost utility analysis of survival in epoetin alfa- versus placebo-treated stage IV breast cancer patients. Pharmacoeconomics (in press)
   Web of Science ®Google Scholar
• Remák E, Hutton J, Jones M, Zagari M. Changes in cost-effectiveness over time – the case of EPO in renal replacement therapy patients in the UK. Eur J Health Econ 2003;4:115–21
   PubMedGoogle Scholar
• Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfusion Med 2003;13:205–13
   PubMed Web of Science ®Google Scholar
• Department of Health. Better blood transfusion: appropriate use of blood. Health Service Circular 2002/009. London: Department of Health
   Google Scholar
• Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and pre-cancer screening: preselecting high-risk individuals. Commun Dental Health 1998;15:72–6
   PubMedGoogle Scholar
• Brown ML, Riley GF, Potosky AL, et al. Obtaining long term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer. Med Care 1999;37:1249–59
   PubMed Web of Science ®Google Scholar
• Wright EP, Kiely MA, Lynch P, et al. Social problems in oncology. Br J Cancer 2002;87:1099–104
   PubMed Web of Science ®Google Scholar
• Hayman JA, Langa KM, Kabeto MU, et al. Estimating the cost of informal caregiving for elderly patients with cancer. J Clin Oncol 2001;19:3219–25
   PubMed Web of Science ®Google Scholar
• Aranda S, Hayman-White K. Home caregivers of the person with advanced cancer: an Australian perspective. Cancer Nursing 2001;24:301–7
   Google Scholar
• UK Renal Registry. Fifth Annual Report 2002. Bristol: Renal Association, 2002
   Google Scholar
• Department of Health. The NHS Cancer Plan. London: Department of Health, 2000
   Google Scholar
• Department of Health. The Inquiry into the management of care of children receiving complex heart surgery at the Bristol Royal Infirmary. London: Department of Health, 2002
   Google Scholar
• Thomas H. Integrating Care, 2003. Personal communication
   Google Scholar
• Breast Cancer Coalition. The Best Treatment. London: Breast Cancer Coalition, 2002
   Google Scholar